What Researchers Did
Researchers investigated changes in oxidative stress markers (malondialdehyde, 8-isoprostane, and advanced oxidation protein products) in 20 diabetic patients receiving hyperbaric oxygen therapy for foot ulcers.
What They Found
After the first hyperbaric oxygen therapy (HBOT) session, malondialdehyde (MDA) levels significantly increased. By the fifteenth session, 8-isoprostane and advanced oxidation protein products (AOPP) levels significantly increased (p<0.05), yet overall plasma AOPP levels were significantly lowered after fifteen consecutive HBOT sessions.
What This Means for Canadian Patients
For Canadian patients with diabetic foot ulcers, hyperbaric oxygen therapy may have a complex impact on oxidative stress, initially increasing some markers but potentially reducing overall protein oxidation after multiple sessions. This suggests that HBOT could activate protective mechanisms, potentially aiding in the management of chronic oxidative damage associated with diabetes.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
A limitation of this study is its small sample size of 20 patients and the relatively short observation period.